Amylyx Pharmaceuticals Newsroom

Investors Don't See Light At End Of Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Tunnel And Push Stock Down 26%

Simply Wall St14:15 ET

Selling Amylyx Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall StDec 11 07:03 ET

BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Announces Target Price $10

Moomoo NewsDec 5 12:31 ET · Ratings

H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsDec 5 12:31 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $12 Price Target

BenzingaDec 5 07:07 ET

Express News | Amylyx Pharmaceuticals Shares up 1.7% on Late-Stage Trial Update for Low-Blood Sugar Drug

ReutersDec 4 09:50 ET

Amylyx Pharmaceuticals Says Pivotal Phase 3 LUCIDITY Will Evaluate FDA-Agreed Upon Primary Outcome Of Reduction In Hypoglycemia Events And Designed To Align As Closely As Possible With Previous Phase 2 Trial Designs

BenzingaDec 4 07:34 ET

Express News | Amylyx Pharmaceuticals Inc - First Participant in Lucidity Trial Expected in Q1 2025

ReutersDec 4 07:30 ET

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

BusinesswireDec 4 07:30 ET

Express News | Amylyx Pharmaceuticals Announces Pivotal Phase 3 Lucidity Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

ReutersDec 4 07:30 ET

Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference

BusinesswireNov 27 09:00 ET

Baird Upgrades Amylyx Pharmaceuticals(AMLX.US) to Buy Rating, Raises Target Price to $11

Moomoo NewsNov 19 03:36 ET · Ratings

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

BenzingaNov 18 09:59 ET

This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

BenzingaNov 18 08:07 ET

Amylyx Pharmaceuticals Raised to Outperform From Neutral by Baird

Dow JonesNov 18 07:36 ET · Ratings

Strong Buy Rating for Amylyx Pharmaceuticals Inc. Driven by Promising Avexitide Prospects and Stable Financial Standing

TipRanksNov 18 05:05 ET · Ratings

Cautious Hold on Amylyx Pharmaceuticals Amid Uncertainty in Pipeline Progress

TipRanksNov 11 01:29 ET · Ratings

Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 9 10:25 ET · Conference Call

Amylyx Pharma Analyst Ratings

BenzingaNov 8 07:34 ET · Ratings

H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsNov 8 07:31 ET · Ratings